Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients

Abstract Purpose To investigate the features and treatment response in Caucasian patients with polypoidal choroidal vasculopathy (PCV), initially treated with bevacizumab. Methods 45 eyes of 43 treatment-naïve patients with PCV were included in this retrospective study, all uniformly initially treat...

Full description

Bibliographic Details
Main Authors: Fidaa El Zhalka, Elad Moisseiev, Alexander Rubowitz
Format: Article
Language:English
Published: BMC 2022-11-01
Series:International Journal of Retina and Vitreous
Online Access:https://doi.org/10.1186/s40942-022-00432-x